Robert E. Dudley - 09 Sep 2021 Form 3 Insider Report for Clarus Therapeutics Holdings, Inc.

Role: Chief Executive Officer, Director
Signature: /s/ Steven A. Bourne, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 09 Sep 2021
Net transactions value: $0
Form type: 3
Filing time: 13 Sep 2021, 20:29:43 UTC
Next filing: 14 Dec 2021
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24: Power of Attorney